首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature
【24h】

Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature

机译:沟通药物安全问题的意外影响:对文献的关键综述

获取原文
获取原文并翻译 | 示例
           

摘要

Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the unintended effects from communicating information to the public about safety issues with prescription and over-the-counter drugs. We searched PubMed for peer-reviewed studies published from 1990 to 2017 where study authors reported probable unintended effects of communicating drug safety. The types of communications included in these studies were news reports, direct-to-consumer advertisements, and those released by government agencies. Among the 26 studies identified, the most commonly reported unintended effects were decreased drug use or discontinuation. Other unintended effects included spillover to populations not targeted by the communications (e.g., discontinuation of antidepressants among adults following communications concerning use among youth), shifts in clinical diagnoses (e.g., fewer diagnoses of depression), increased use of alternative therapies, and other undesirable behaviors (e.g., possible increased suicide attempts because antidepressants were discontinued). Limitations to the literature include the inability to establish causation or to isolate the effects of multiple communication sources and messages. Further, because the intended effect of many communications was not known, our study was limited by challenges in defining some effects as unintended. Most studies used health insurer claims data to identify unintended effects of communications, which provide an incomplete picture; few used self-reported or other methodologies that could help illuminate the reasons underlying the effects observed in the claims data. Best practices for communicating about the potential benefits and harms of drugs in a manner that minimizes negative unintended effects are needed to protect and improve public health.
机译:关于人类药物的安全和有效性的通信可以影响患者和规定的感知和行为,这反过来可能会更广泛地影响公众的健康状况。我们对宣传信息与处方和逆毒品的安全问题的意外效果对文献进行了一项重大审查。我们搜索了1990年至2017年发布的同伴评测研究的PubMed,研究作者报告了沟通药物安全的意外影响可能。这些研究中包含的通信类型是新闻报道,直接消费广告,以及政府机构发布的通信。在确定的26项研究中,最常见的报告的意外效应减少了药物使用或停药。其他意想不到的效果包括溢出到未经通信所针对的人群(例如,在青年使用的通信后的成年人中停止抗抑郁药),临床诊断(例如,抑郁诊断的诊断),增加使用替代疗法,以及其他不受欢迎的行为(例如,可能会增加自杀型尝试,因为抗抑郁药被停止)。对文献的限制包括无法建立因果关系或隔离多个通信来源和消息的影响。此外,由于许多通信的预期效果尚不清楚,我们的研究受到限制定义某种效果的挑战。大多数研究使用健康保险公司声称数据以确定通信的意外影响,这提供了不完整的图片;少数使用的自我报告或其他方法可以帮助照亮索赔数据中观察到的效果的原因。以一种最大限度地减少负面意外效应的方式沟通药物潜在益处和危害的最佳实践是为了保护和改善公共卫生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号